β-arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice

Journal of Bone and Mineral Research

Volumn 20, Issue 4, 2005, Pages 635-643

  Bouxsein, Mary L ^a,c   Pierroz, Dominique D ^b   Glatt, Vaida ^a   Goddard, Deborah S ^a   Cavat, Fanny ^b   Rizzoli, René ^b   Ferrari, Serge L ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

arrestin; Bone architecture; Bone remodeling; Knockout; PTH

Indexed keywords

BETA ARRESTIN; BETA ARRESTIN2; BIOCHEMICAL MARKER; CYCLIC AMP; ESTROGEN; OSTEOCALCIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PROTEIN; TRACP5B PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE GROWTH; BONE MARROW; BONE MASS; BONE REMODELING; BONE STRUCTURE; BONE TURNOVER; CANCELLOUS BONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; CORTICAL BONE THICKNESS; DOSE RESPONSE; DRUG EFFECT; DRUG INTERMITTENT THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOSTEUM; ENDOTHELIUM; ESTROGEN DEFICIENCY; FEMALE; FEMUR; HORMONE ACTION; HORMONE RESPONSE; MORPHOMETRICS; MOUSE; MOUSE MUTANT; NONHUMAN; OSTEOLYSIS; PERIOSTEUM; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THICKNESS; TRABECULAR BONE; TRABECULAR BONE VOLUME FRACTION;

ANIMALS; ARRESTINS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; FEMALE; FEMUR; MICE; MICE, KNOCKOUT; PARATHYROID HORMONE; SIGNAL TRANSDUCTION;

EID: 15344347049     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.041204     Document Type: Article

References (54)

1. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
2. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16: 1846-1853.
3. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF 2003 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932-1941.
4. Horwitz M, Stewart A, Greenspan SL 2000 Sequential parathyroid hormone/alendronate therapy for osteoporosis-robbing Peter to pay Paul? J Clin Endocrinol Metab 85:2127-2128.
5. Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM 2001 Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16: 157-165.
6. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ 2003 The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207-1215.
7. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM 2003 The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349: 1216-1226.
8. Zanchetta J, Bogado C, Ferretti J, Wang O, Wilson M, Sato M, Gaich G, Dalsky G, Myers S 2003 Effects of teripoaratide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539-543.
9. Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 1999 Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536-545.
10. Hirano T, Burr DB, Cain RL, Hock JM 2000 Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34). Calcif Tissue Int 66:456-460. 6.htm.
11. Mashiba T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 2001 Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. Bone 28:538-547.
12. Sato M, Westmore M, Ma YL, Schmidt A, Zeng QQ, Glass EV, Vahle J, Brommage R, Jerome CP, Turner CH 2004 Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res 19:623-629.
13. Rehman Q, Lang TF, Arnaud CD, Modin GW, Lane NE 2003 Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 14:77-81.
14. Kneissel M, Boyde A, Gasser JA 2001 Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). Bone 28:237-250.
15. Parfitt AM 2002 Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17:1741-1743.
16. Hock JM 2000 Discrimination among osteoblasts? Parathyroid hormone analog may reveal site-specific differences in mice. Bone 27:467-469.
17. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E 2001 Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107:277-286.
18. Bouxsein M 2001 Biomechanics of age-related fractures. In: Marcus R, Feldman D, Kelsey J (eds.) Osteoporosis, 2nd ed. Academic Press, San Diego, CA, USA, pp. 509-534.
19. Rixon RH, Whitfield JF, Gagnon L, Isaacs RJ, Maclean S, Chakravarthy B, Durkin JP, Neugebauer W, Ross V, Sung W, Willick GE 1994 Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 9:1179-1189.
20. Hilliker S, Wergedal JE, Gruber HE, Bettica P, Baylink DJ 1996 Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone 19:469-477.
21. Armamento-Villareal R, Ziambaras K, Abbasi-Jarhomi SH, Dimarogonas A, Halstead L, Fausto A, Avioli LV, Civitelli R 1997 An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats. J Bone Miner Res 12:384-392.
22. Luttrell LM, Lefkowitz RJ 2002 The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115:455-465.
23. Ferrari SL, Behar V, Chorev M, Rosenblatt M, Bisello A 1999 Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem 274:29968-29975.
24. Castro M, Dicker F, Vilardaga JP, Krasel C, Bernhardt M, Lohse MJ 2002 Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and beta-arrestins. Endocrinology 143:3854-3865.
25. Perry SJ, Baillie GS, Kohout TA, McPhee I, Magiera MM, Ang KL, Miller WE, McLean AJ, Conti M, Houslay MD, Lefkowitz RJ 2002 Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298:834-836.
26. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT 1999 Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-2498.
27. Bohn LM, Lefkowitz RJ, Caron MG 2002 Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 22:10494-10500.
28. Bliziotes M, Murtagh J, Wiren K 1996 Beta-adrenergic receptor kinase-like activity and beta-arrestin are expressed in osteoblastic cells. J Bone Miner Res 11:820-826.
29. Spurney RF 2003 Regulated expression of G protein-coupled receptor kinases (GRK's) and beta-arrestins in osteoblasts. Calcif Tissue Int 73:153-160.
30. Nagy TR, Clair AL 2000 Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 8:392-398.
31. Nagy TR, Prince CW, Li J 2001 Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats. J Bone Miner Res 16:1682-1687.
32. Iida-Klein A, Lu SS, Yokayama K, Dempster DW, Nieves J, Lindsay R 2003 Precision, accuracy, and reproducibility of dual X-ray absorptiometry measurements in mice in vivo. J Clin Densitom 6:25-33.
33. Hildebrand T P R 1997 A new method for the model independent assessment of thickness in three-dimensional images. J Microsc 185:67-75.
34. Hildebrand T, Rüesegger P 1997 Quantification of bone microarchitecture with the structure model index. Comp Meth Biomech Biomed Eng 1:5-23.
35. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P 1999 Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:1167-1174.
36. Parfitt A, Drezner M, Glorieux F, Kanis J, Recker R 1987 Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Miner Res 2:595-610.
37. Rizzoli R, Caverzasio J, Chapuy MC, Martin TJ, Bonjour JP 1989 Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats. J Bone Miner Res 4:759-765.
38. Riggs BL, Khosla S, Melton LJ III 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302.
39. Bouxsein ML, Sternlight D, Glatt V, Pierroz D, Ferrari SL 2002 Intermittent PTH fails to restore deficient bone mass and microarchitecture in male mice null for β-arrestin2. J Bone Miner Res 17:S1;S140.
40. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317.
41. Lin FT, Daaka Y, Lefkowitz RJ 1998 beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J Biol Chem 273:31640-31643.
42. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC 2003 Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 301:1394-1397.
43. McCarthy TL, Ji C, Centrella M 2000 Links among growth factors, hormones, and nuclear factors with essential roles in bone formation. Crit Rev Oral Biol Med 11:409-422.
44. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781.
45. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B 2001 The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16:2320-2329.
46. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL 2002 Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.
47. Bouxsein ML, Rosen CJ, Turner CH, Ackert CL, Shultz KL, Donahue LR, Churchill G, Adamo ML, Powell DR, Turner RT, Muller R, Beamer WG 2002 Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo. J Bone Miner Res 17:570-579.
48. Mohan S, Kutilek S, Zhang C, Shen HG, Kodama Y, Srivastava AK, Wergedal JE, Beamer WG, Baylink DJ 2000 Comparison of bone formation responses to parathyroid hormone(1-34), (1- 31), and (2-34) in mice. Bone 27:471-478.
49. Alexander J, Bab I, Fish S, Müller R, Uchiyama T, Gronowicz G, Nahounou N, Zhao Q, White D, Chorev M, Gazit D, Rosenblatt M 2001 Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. J Bone Miner Res 16:1665-1673.
50. Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R 2002 Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 17:808-816.
51. Zhou H, Iida-Klein A, Lu SS, Ducayen-Knowles M, Levine LR, Dempster DW, Lindsay R 2003 Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice. Bone 32: 513-520.
52. Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M 2003 Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144:2132-2140.
53. Ferrari SL, Bisello A 2001 Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by beta-arrestin2. Mol Endocrinol 15:149-163.
54. Bisello A, Chorev M, Rosenblatt M, Monticelli L, Mierke DF, Ferrari SL 2002 Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J Biol Chem 277:38524-38530.